Hobart Private Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-3,976
| Closed | -$274K | – | 106 |
|
|
2021
Q2 | $274K | Sell |
3,976
-265
| -6% | -$18.2K | 0.11% | 107 |
|
|
2021
Q1 | $274K | Sell |
4,241
-2,929
| -41% | -$189K | 0.11% | 113 |
|
|
2020
Q4 | $418K | Sell |
7,170
-8,328
| -54% | -$485K | 0.18% | 99 |
|
|
2020
Q3 | $979K | Buy |
15,498
+10,334
| +200% | +$653K | 0.51% | 31 |
|
|
2020
Q2 | $397K | Sell |
5,164
-16,010
| -76% | -$1.23M | 0.22% | 110 |
|
|
2020
Q1 | $1.58M | Buy |
21,174
+1,962
| +10% | +$147K | 1.09% | 21 |
|
|
2019
Q4 | $1.25M | Buy |
19,212
+1,050
| +6% | +$68.2K | 0.76% | 34 |
|
|
2019
Q3 | $1.15M | Buy |
+18,162
| New | +$1.15M | 0.78% | 37 |
|